Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Filings indexed 1,622 across all filing types
Latest filing 2022-08-18 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
中德证券有限责任公司关于天域生态环境股份有限公司非公开发行股票涉及关联交易事项的核查意见
Regulatory Filings
2022-08-18 Chinese
独立董事关于公司第三届董事会第四十六次会议相关议案的独立意见
Regulatory Filings
2022-08-17 Chinese
独立董事关于公司第三届董事会第四十六次会议相关议案的事前认可意见
Regulatory Filings
2022-08-17 Chinese
第三届董事会第四十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of Tianyu Ecological Environment Co., Ltd. It includes multiple agenda items such as approval of using idle raised funds for working capital, approval of conditions for a non-public stock issuance, details of the stock issuance plan, related party transactions, and authorization for the board to handle related matters. It also mentions that these resolutions will be submitted to the shareholders' meeting for approval. The document is not a full financial report, earnings release, or audit report. It is not a proxy solicitation or voting results announcement but rather a formal announcement of board meeting decisions, including management and board resolutions. Therefore, it fits best under the category of Board/Management Information (MANG). The document length (7031 characters) and content confirm it is a full announcement of board meeting resolutions, not just a brief notice or report publication announcement.
2022-08-17 Chinese
天域生态 未来三年(2022年-2024年)股东回报规划
Notice of Dividend Amount Classification · 95% confidence The document is titled as a "Three-Year Shareholder Return Plan (2022-2024)" for Tianyu Ecological Environment Co., Ltd. It details the company's profit distribution policy, dividend payment principles, decision-making procedures, and mechanisms for shareholder returns over the next three years. The content focuses on dividend policy and shareholder return planning rather than reporting actual financial results or earnings. The document is relatively short (2427 characters) and does not contain financial statements or earnings data. It is a formal announcement of the company's dividend and shareholder return policy, which aligns with the category of Notice of Dividend Amount (DIV), as it outlines dividend distribution plans and policies for shareholders.
2022-08-17 Chinese
天域生态 非公开发行股票募集资金使用可行性分析报告
Capital/Financing Update Classification · 95% confidence The document is titled '非公开发行股票募集资金使用 可行性分析报告' which translates to 'Non-public Issuance of Shares Fundraising Usage Feasibility Analysis Report'. It discusses the plan and feasibility of using funds raised from a non-public stock issuance, including the necessity, feasibility, and impact on the company's financial structure and operations. The document is dated August 2022 and is issued by the company's board. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement of a report publication. It is a detailed analysis report related to capital raising activities, specifically the use of proceeds from a private placement of shares. This fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is 1841 characters, which is short but contains substantive content about the fundraising plan and its feasibility, not just an announcement or certification. Therefore, the classification is CAP with high confidence.
2022-08-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.